SEC Form 4 · accession 0001209191-18-042363
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hamza Suria
Officer — President, CEO · Director
Period of report
Jul 9, 2018
Accepted (ET)
Jul 11, 2018 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 9, 2018 | M | 1,428 | $2.24 | A | 28,854 | D | |
| Common Stock | Jul 9, 2018 | M | 6,208 | $1.61 | A | 35,062 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.24 | Jul 9, 2018 | M | 1,428 | D | — | Feb 9, 2020 | Common Stock | 1,428 | 0 | D |
| Employee Stock Option (right to buy)F1 | $1.61 | Jul 9, 2018 | M | 6,208 | D | — | Feb 23, 2021 | Common Stock | 6,208 | 0 | D |
Explanation of responses
- F1The stock option is fully vested and immediately exercisable.